Bürger T, Meyer F, Tautenhahn J, Halloul Z, Fahlke J
Hospital for General, Abdominal, and Vascular Surgery, Surgical Center, Medical Faculty, Otto von Guericke University, Magdeburg, Germany.
J Endovasc Surg. 1998 Nov;5(4):365-72. doi: 10.1583/1074-6218(1998)005<0365:IEWPER>2.0.CO;2.
To report the percutaneous endovascular management of popliteal artery lesions with a new polytetrafluoroethylene (PTFE) stent-graft.
Three patients have undergone endovascular treatment in the popliteal region owing to: (1) an iatrogenic false aneurysm with arteriovenous fistula, (2) entrapment syndrome, and (3) an isolated arterial aneurysm. In each case, arterial occlusion was treated initially with thrombolysis. The underlying vascular lesions then were stented using the new Hemobahn endograft, a nitinol stent covered internally with PTFE. Each percutaneous procedure was completed successfully without major complications. During early follow-up (6 to 7 months), no signs of intimal hyperplasia, occlusion, or stent migration have been observed.
Based on these early experiences, percutaneous treatment of stenotic and aneurysmal lesions in the popliteal artery using the Hemobahn endograft appears feasible and effective. Further experience and longer follow-up are required to evaluate this new prosthesis.
报告使用新型聚四氟乙烯（PTFE）覆膜支架对腘动脉病变进行经皮血管腔内治疗的情况。
3例患者因以下情况接受了腘动脉区域的血管腔内治疗：（1）医源性假性动脉瘤伴动静脉瘘；（2）腘动脉陷迫综合征；（3）孤立性动脉瘤。每例患者最初均采用溶栓治疗动脉闭塞。随后使用新型Hemobahn腔内移植物对潜在的血管病变进行支架置入，该移植物为内部覆盖PTFE的镍钛合金支架。每次经皮手术均成功完成，无重大并发症。在早期随访（6至7个月）期间，未观察到内膜增生、闭塞或支架移位的迹象。
基于这些早期经验，使用Hemobahn腔内移植物经皮治疗腘动脉狭窄和动脉瘤性病变似乎可行且有效。需要进一步的经验和更长时间的随访来评估这种新型假体。
